The rising incidence of chronic diseases such as cancer and neurological illnesses are driving the demand for image guided surgery devices across the world. According to the World Health Organization (WHO), cancer was the second leading cause of deaths around the world and accounted for nearly 9.6 million deaths or one out of every six deaths in 2018. Furthermore, the organization reported that over 6 million deaths are caused due to stroke every year.
Study and Analyze the Global Image Guided Surgery Devices Market size
Apart from the aforementioned factor, the mushrooming population of older people is also positively impacting the worldwide demand for image guided surgery devices. As per the World Population Ageing 2020 report published by the United Nations Department of Economic and Social Affairs (UNDESA), the population of people aged 65 years or above will rise from 727 million in 2020 to more than 1.5 billion by 2050. Furthermore, the population of people aged 60 years and above is predicted to rise to around 437 million, 324 million, 107 million, and 58 million in China, India, the U.S., and Brazil, respectively, by 2050.
Ultrasound, computed tomography (CT), X-Ray fluoroscopy, magnetic resonance imaging (MRI), endoscopes, single-photon emission computed tomography (SPECT), and positron emission tomography (PET) are the majorly used image guided surgery devices across the world. Out of these, the demand for CT devices was found to be the highest in the years gone by. This was because CT scans help in the early diagnosis of various vascular diseases, cancer, and skeletal abnormalities by showing tissues, organs, and bones in a thin slice of the body.
Hence, it can be said without any hesitation that the demand for image guided surgery devices will soar sharply in the coming years, primarily because of the growing incidence of neurological diseases and chronic illnesses and the surging population of geriatric people across the world.